Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Traynor

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Investigational New Drugs|May 13, 2009
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumorsAnne M Traynor, Michael S Gordon, Dona Alberti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2012
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancerR C Doebele, P Conkling, A M Traynor, et al.
Critical Care Medicine|November 6, 2018
Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems DatabaseRobert B Lindell, Akira Nishisaki, Scott L Weiss, et al.
Cancer|October 24, 2006
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaHoward H Bailey, Michelle R Mahoney, David S Ettinger, et al.
Journal of Industrial Microbiology & Biotechnology|March 17, 2023
Effect of nitrogen management in cultivation on the stability and microbial community of post-harvest Monoraphidium sp. algae biomassBradley D Wahlen, Lynn M Wendt, Chelsea C St Germain, et al.
Psychopathology|January 2, 2025
Under and Overmentalizing in Personality Disorders: A Principal Component Analysis of Nonadaptive Personality and the Movie Assessment of Social CognitionJulia Jurist, Jenna M Traynor, Grace E Murray, et al.
Head & Neck|September 17, 2009
Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experienceAnne M Traynor, Gregory M Richards, Gregory K Hartig, et al.
Clinical Lung Cancer|June 9, 2024
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung CancerRachel L Minne, Natalie Y Luo, Anne M Traynor, et al.
The Journal of Surgical Research|February 25, 2014
Metastasis of primary lung carcinoma to the breast: a systematic review of the literatureJennifer A Mirrielees, Jaime H Kapur, Linda M Szalkucki, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2014
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancerKari B Wisinski, Wendy M Ledesma, Jill Kolesar, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Investigational New Drugs|May 13, 2009
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumorsAnne M Traynor, Michael S Gordon, Dona Alberti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2012
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancerR C Doebele, P Conkling, A M Traynor, et al.
Critical Care Medicine|November 6, 2018
Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems DatabaseRobert B Lindell, Akira Nishisaki, Scott L Weiss, et al.
Cancer|October 24, 2006
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaHoward H Bailey, Michelle R Mahoney, David S Ettinger, et al.
Journal of Industrial Microbiology & Biotechnology|March 17, 2023
Effect of nitrogen management in cultivation on the stability and microbial community of post-harvest Monoraphidium sp. algae biomassBradley D Wahlen, Lynn M Wendt, Chelsea C St Germain, et al.
Psychopathology|January 2, 2025
Under and Overmentalizing in Personality Disorders: A Principal Component Analysis of Nonadaptive Personality and the Movie Assessment of Social CognitionJulia Jurist, Jenna M Traynor, Grace E Murray, et al.
Head & Neck|September 17, 2009
Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experienceAnne M Traynor, Gregory M Richards, Gregory K Hartig, et al.
Clinical Lung Cancer|June 9, 2024
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung CancerRachel L Minne, Natalie Y Luo, Anne M Traynor, et al.
The Journal of Surgical Research|February 25, 2014
Metastasis of primary lung carcinoma to the breast: a systematic review of the literatureJennifer A Mirrielees, Jaime H Kapur, Linda M Szalkucki, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 3, 2014
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancerKari B Wisinski, Wendy M Ledesma, Jill Kolesar, et al.
Pageof 17